Kathleen Poston, MD, MS

Movement disorders specialist

Movement Disorders Center

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-723-6469
Learn More About the Clinic Getting Here Make An Appointment

Deep Brain Stimulation Program

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-723-6469
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Medical Education: Vanderbilt University School of Medicine (2002) TN

Internship: Univ of California San Francisco (2003) CA

Residency: Univ of California San Francisco (2006) CA

Fellowship: Columbia University Medical Center (2008) NY

Board Certification: Neurology, American Board of Psychiatry and Neurology (2007)

Post-Doc, Feinstein Institute, Functional Neuroimaging (2009)

BSE, University of Pennsylvania, Bioengineering

MS, Vanderbilt University, Bioengineering (1998)

Honors & Awards

Lysia Forno Award for Teaching Excellence, Stanford University (2009-2010)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Hospital & Clinics patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Functional brain networks and abnormal connectivity in the movement disorders
Poston, K. L., & Eidelberg, D. (2012). Functional brain networks and abnormal connectivity in the movement disorders. NEUROIMAGE, 62(4), 2261-2270.

Network correlates of disease severity in multiple system atrophy
Poston, K. L., Tang, C. C., Eckert, T., Dhawan, V., Frucht, S., & Eidelberg, D. (2012). Network correlates of disease severity in multiple system atrophy. NEUROLOGY, 78(16), 1237-1244.

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., & Feigin, A. (2011). AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. LANCET NEUROLOGY, 10(4), 309-319.

Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis
Tang, C. C., Poston, K. L., Eckert, T., Feigin, A., Frucht, S., & Eidelberg, D. (2010). Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. LANCET NEUROLOGY, 9(2), 149-158.

Abnormalities in Metabolic Network Activity Precede the Onset of Motor Symptoms in Parkinson's Disease
Tang, C. C., Poston, K. L., Dhawan, V., & Eidelberg, D. (2010). Abnormalities in Metabolic Network Activity Precede the Onset of Motor Symptoms in Parkinson's Disease. JOURNAL OF NEUROSCIENCE, 30(3), 1049-1056.

Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) with Myoclonus
Poston, K. L., McGovern, R. A., Goldman, J. S., Caccappolo, E., & Mazzoni, P. (2010). Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) with Myoclonus. MOVEMENT DISORDERS, 25(4), 514-516.

FDG PET in the Evaluation of Parkinson's Disease.
Poston, K. L., & Eidelberg, D. (2010). FDG PET in the Evaluation of Parkinson's Disease. PET clinics, 5(1), 55-64.

Action tremor of the legs in essential tremor: Prevalence, clinical correlates, and comparison with age-matched controls
Poston, K. L., Rios, E., & Louis, E. D. (2009). Action tremor of the legs in essential tremor: Prevalence, clinical correlates, and comparison with age-matched controls. PARKINSONISM & RELATED DISORDERS, 15(8), 602-605.

Network biomarkers for the diagnosis and treatment of movement disorders
Poston, K. L., & Eidelberg, D. (2009). Network biomarkers for the diagnosis and treatment of movement disorders. NEUROBIOLOGY OF DISEASE, 35(2), 141-147.

Movement disorder emergencies
Poston, K. L., & Frucht, S. J. (2008). Movement disorder emergencies. JOURNAL OF NEUROLOGY, 255, 2-13.

Zydis selegilline in the management of Parkinson's disease
Poston, K. L., & Waters, C. (2007). Zydis selegilline in the management of Parkinson's disease. EXPERT OPINION ON PHARMACOTHERAPY, 8(15), 2615-2624.